{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:48:10Z","timestamp":1793998090121,"version":"4.8.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T00:00:00Z","timestamp":1747353600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82260555"],"award-info":[{"award-number":["82260555"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360550"],"award-info":[{"award-number":["82360550"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82303474"],"award-info":[{"award-number":["82303474"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Nanobiotechnol"],"DOI":"10.1186\/s12951-025-03424-9","type":"journal-article","created":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T08:55:50Z","timestamp":1747385750000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["A spreadable self-gelling hemostatic powder sensitizes CAR-NK cell therapy to prevent hepatocellular carcinoma recurrence postresection"],"prefix":"10.1186","volume":"23","author":[{"given":"Yusheng","family":"Cheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihang","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanxin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haofei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixiong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiangen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wence","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,16]]},"reference":[{"issue":"1","key":"3424_CR1","doi-asserted-by":"publisher","first-page":"12","DOI":"10.3322\/caac.21820","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74(1):12\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"3424_CR2","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.livres.2024.05.001","volume":"8","author":"X Liu","year":"2024","unstructured":"Liu X, Xia F, Chen Y, Sun H, Yang Z, Chen B, et al. Chinese expert consensus on refined diagnosis, treatment, and management of advanced primary liver cancer (2023 edition). Liver Res. 2024;8(2):61\u201371.","journal-title":"Liver Res"},{"issue":"1D","key":"3424_CR3","first-page":"e237069","volume":"22","author":"Y He","year":"2023","unstructured":"He Y, Luo L, Shan R, Qian J, Cui L, Wu Z, et al. Development and validation of a nomogram for predicting postoperative early relapse and survival in hepatocellular carcinoma. J Natl Compr Canc Netw. 2023;22(1D):e237069.","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"3424_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.livres.2024.05.003","volume":"8","author":"H Wei","year":"2024","unstructured":"Wei H, Luo S, Bi Y, Liao C, Lian Y, Zhang J, et al. Plasma microRNA-15a\/16-1-based machine learning for early detection of hepatitis B virus-related hepatocellular carcinoma. Liver Res. 2024;8(2):105\u201317.","journal-title":"Liver Res"},{"key":"3424_CR5","doi-asserted-by":"publisher","first-page":"121506","DOI":"10.1016\/j.biomaterials.2022.121506","volume":"284","author":"Y Cheng","year":"2022","unstructured":"Cheng Y, Gong Y, Chen X, Zhang Q, Zhang X, He Y, et al. Injectable adhesive hemostatic gel with tumor acidity neutralizer and neutrophil extracellular traps lyase for enhancing adoptive NK cell therapy prevents post-resection recurrence of hepatocellular carcinoma. Biomaterials. 2022;284:121506.","journal-title":"Biomaterials"},{"key":"3424_CR6","doi-asserted-by":"crossref","unstructured":"Wang J, Yu H, Dong W, Zhang C, Hu M, Ma W et al. N6-Methyladenosine-Mediated Up-Regulation of FZD10 Regulates Liver Cancer Stem Cells\u2019 Properties and Lenvatinib Resistance Through WNT\/\u03b2-Catenin and Hippo Signaling Pathways. Gastroenterology. 2023;164(6).","DOI":"10.1053\/j.gastro.2023.01.041"},{"key":"3424_CR7","doi-asserted-by":"crossref","unstructured":"Park DJ, Sung PS, Kim J-H, Lee GW, Jang JW, Jung ES et al. EpCAM-high liver cancer stem cells resist natural killer cell-mediated cytotoxicity by upregulating CEACAM1. J Immunother Cancer. 2020;8(1).","DOI":"10.1136\/jitc-2019-000301"},{"issue":"1","key":"3424_CR8","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.cellimm.2007.03.004","volume":"245","author":"TD Cunningham","year":"2007","unstructured":"Cunningham TD, Jiang X, Shapiro DJ. Expression of high levels of human proteinase inhibitor 9 blocks both Perforin\/granzyme and Fas\/Fas ligand-mediated cytotoxicity. Cell Immunol. 2007;245(1):32\u201341.","journal-title":"Cell Immunol"},{"issue":"1","key":"3424_CR9","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1186\/s12967-022-03437-0","volume":"20","author":"J Chu","year":"2022","unstructured":"Chu J, Gao F, Yan M, Zhao S, Yan Z, Shi B, et al. Natural killer cells: a promising immunotherapy for cancer. J Transl Med. 2022;20(1):240.","journal-title":"J Transl Med"},{"key":"3424_CR10","doi-asserted-by":"publisher","first-page":"108114","DOI":"10.1016\/j.pharmthera.2022.108114","volume":"235","author":"S Joshi","year":"2022","unstructured":"Joshi S, Sharabi A. Targeting myeloid-derived suppressor cells to enhance natural killer cell-based immunotherapy. Pharmacol Ther. 2022;235:108114.","journal-title":"Pharmacol Ther"},{"issue":"1","key":"3424_CR11","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1002\/ctm2.24","volume":"10","author":"F Tang","year":"2020","unstructured":"Tang F, Tie Y, Tu C, Wei X. Surgical trauma-induced immunosuppression in cancer: recent advances and the potential therapies. Clin Transl Med. 2020;10(1):199\u2013223.","journal-title":"Clin Transl Med"},{"issue":"3","key":"3424_CR12","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.jhep.2018.10.040","volume":"70","author":"SJ Yu","year":"2019","unstructured":"Yu SJ, Ma C, Heinrich B, Brown ZJ, Sandhu M, Zhang Q, et al. Targeting the crosstalk between cytokine-induced killer cells and myeloid-derived suppressor cells in hepatocellular carcinoma. J Hepatol. 2019;70(3):449\u201357.","journal-title":"J Hepatol"},{"key":"3424_CR13","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1073\/pnas.2102718118","volume":"118","author":"S Bugide","year":"2021","unstructured":"Bugide S, Gupta R, Green MR, Wajapeyee N. EZH2 inhibits NK cell-mediated antitumor immunity by suppressing CXCL10 expression in an HDAC10-dependent manner. Proc Natl Acad Sci U S A. 2021;118:30.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"3424_CR14","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1038\/s41591-023-02369-6","volume":"29","author":"J Lv","year":"2023","unstructured":"Lv J, Wei Y, Yin J-H, Chen Y-P, Zhou G-Q, Wei C, et al. The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment. Nat Med. 2023;29(6):1424\u201336.","journal-title":"Nat Med"},{"issue":"15","key":"3424_CR15","doi-asserted-by":"publisher","first-page":"4437","DOI":"10.7150\/thno.34953","volume":"9","author":"C Hong","year":"2019","unstructured":"Hong C, Wang D, Liang J, Guo Y, Zhu Y, Xia J, et al. Novel ginsenoside-based multifunctional liposomal delivery system for combination therapy of gastric cancer. Theranostics. 2019;9(15):4437\u201349.","journal-title":"Theranostics"},{"key":"3424_CR16","doi-asserted-by":"crossref","unstructured":"Sun S, Tang Q, Wang Y, Zhang L, Chen J, Xu M et al. In situ Micro-Nano conversion augmented Tumor-Localized immunochemotherapy. ACS Appl Mater Interfaces. 2022.","DOI":"10.1021\/acsami.2c02490"},{"issue":"23","key":"3424_CR17","doi-asserted-by":"publisher","first-page":"e2201271","DOI":"10.1002\/advs.202201271","volume":"9","author":"Y Gong","year":"2022","unstructured":"Gong Y, Chen W, Chen X, He Y, Jiang H, Zhang X, et al. An injectable epigenetic autophagic modulatory hydrogel for boosting umbilical cord blood NK cell therapy prevents postsurgical relapse of Triple-Negative breast Cancer. Adv Sci (Weinh). 2022;9(23):e2201271.","journal-title":"Adv Sci (Weinh)"},{"issue":"9","key":"3424_CR18","doi-asserted-by":"publisher","first-page":"e2305508","DOI":"10.1002\/advs.202305508","volume":"11","author":"J-Q Zhu","year":"2024","unstructured":"Zhu J-Q, Wu H, Li X, Li M-Y, Li Z-L, Xu X-F, et al. Hydrogel crosslinked with nanoparticles for prevention of surgical hemorrhage and recurrence of hepatocellular carcinoma. Adv Sci (Weinh). 2024;11(9):e2305508.","journal-title":"Adv Sci (Weinh)"},{"issue":"3","key":"3424_CR19","first-page":"890","volume":"6","author":"L Zhou","year":"2021","unstructured":"Zhou L, Fan L, Zhang F-M, Jiang Y, Cai M, Dai C, et al. Hybrid gelatin\/oxidized chondroitin sulfate hydrogels incorporating bioactive glass nanoparticles with enhanced mechanical properties, mineralization, and osteogenic differentiation. Bioact Mater. 2021;6(3):890\u2013904.","journal-title":"Bioact Mater"},{"key":"3424_CR20","doi-asserted-by":"crossref","unstructured":"Xin Peng XX, Deng Y, Xie X, Xu L, Xu X, Yuan W, Yang B, Yang X. Xianfeng Xia, Li Duan, and liming Bian. Ultrafast Self-Gelling and wet adhesive powder for acute hemostasis and wound healing. Adv Funct Mater. 2021;31(33).","DOI":"10.1002\/adfm.202102583"},{"issue":"7","key":"3424_CR21","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1053\/j.gastro.2023.02.005","volume":"164","author":"C Zhou","year":"2023","unstructured":"Zhou C, Weng J, Liu C, Liu S, Hu Z, Xie X, et al. Disruption of SLFN11 Deficiency-Induced CCL2 signaling and macrophage M2 polarization potentiates Anti-PD-1 therapy efficacy in hepatocellular carcinoma. Gastroenterology. 2023;164(7):1261\u201378.","journal-title":"Gastroenterology"},{"issue":"12","key":"3424_CR22","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1097\/01.tp.0000250935.41034.2d","volume":"82","author":"M Ohira","year":"2006","unstructured":"Ohira M, Ohdan H, Mitsuta H, Ishiyama K, Tanaka Y, Igarashi Y, et al. Adoptive transfer of TRAIL-expressing natural killer cells prevents recurrence of hepatocellular carcinoma after partial hepatectomy. Transplantation. 2006;82(12):1712\u20139.","journal-title":"Transplantation"},{"issue":"2","key":"3424_CR23","doi-asserted-by":"publisher","first-page":"206","DOI":"10.14701\/ahbps.2021.25.2.206","volume":"25","author":"JM Kim","year":"2021","unstructured":"Kim JM, Cho SY, Rhu J, Jung M, Her JH, Lim O, et al. Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study. Ann Hepatobiliary Pancreat Surg. 2021;25(2):206\u201314.","journal-title":"Ann Hepatobiliary Pancreat Surg"},{"issue":"25","key":"3424_CR24","doi-asserted-by":"publisher","first-page":"e2307521","DOI":"10.1002\/smll.202307521","volume":"20","author":"Y Liu","year":"2024","unstructured":"Liu Y, Hao Y, Chen J, Chen M, Tian J, Lv X, et al. An injectable puerarin depot can potentiate chimeric antigen receptor natural killer cell immunotherapy against targeted solid tumors by reversing tumor immunosuppression. Small. 2024;20(25):e2307521.","journal-title":"Small"},{"issue":"8","key":"3424_CR25","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1038\/s12276-020-0471-4","volume":"52","author":"W-J Kim","year":"2020","unstructured":"Kim W-J, Shin H-L, Kim B-S, Kim H-J, Ryoo H-M. RUNX2-modifying enzymes: therapeutic targets for bone diseases. Exp Mol Med. 2020;52(8):1178\u201384.","journal-title":"Exp Mol Med"},{"issue":"1","key":"3424_CR26","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13045-017-0462-7","volume":"10","author":"TP Knutson","year":"2017","unstructured":"Knutson TP, Truong TH, Ma S, Brady NJ, Sullivan ME, Raj G, et al. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs. J Hematol Oncol. 2017;10(1):89.","journal-title":"J Hematol Oncol"},{"key":"3424_CR27","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1186\/s12935-020-01544-w","volume":"20","author":"X Yan","year":"2020","unstructured":"Yan X, Han D, Chen Z, Han C, Dong W, Han L, et al. RUNX2 interacts with BRG1 to target CD44 for promoting invasion and migration of colorectal cancer cells. Cancer Cell Int. 2020;20:505.","journal-title":"Cancer Cell Int"},{"issue":"2","key":"3424_CR28","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1006\/excr.2002.5474","volume":"274","author":"H Drissi","year":"2002","unstructured":"Drissi H, Pouliot A, Koolloos C, Stein JL, Lian JB, Stein GS, et al. 1,25-(OH)2-vitamin D3 suppresses the bone-related Runx2\/Cbfa1 gene promoter. Exp Cell Res. 2002;274(2):323\u201333.","journal-title":"Exp Cell Res"},{"key":"3424_CR29","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.biomaterials.2018.10.022","volume":"189","author":"Y Zhang","year":"2019","unstructured":"Zhang Y, Bush X, Yan B, Chen JA. Gemcitabine nanoparticles promote antitumor immunity against melanoma. Biomaterials. 2019;189:48\u201359.","journal-title":"Biomaterials"},{"key":"3424_CR30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.biomaterials.2016.04.010","volume":"96","author":"MS Sasso","year":"2016","unstructured":"Sasso MS, Lollo G, Pitorre M, Solito S, Pinton L, Valpione S, et al. Low dose gemcitabine-loaded lipid nanocapsules target monocytic myeloid-derived suppressor cells and potentiate cancer immunotherapy. Biomaterials. 2016;96:47\u201362.","journal-title":"Biomaterials"},{"issue":"1","key":"3424_CR31","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12951-020-00589-3","volume":"18","author":"L Pinton","year":"2020","unstructured":"Pinton L, Magri S, Masetto E, Vettore M, Schibuola I, Ingangi V, et al. Targeting of immunosuppressive myeloid cells from glioblastoma patients by modulation of size and surface charge of lipid nanocapsules. J Nanobiotechnol. 2020;18(1):31.","journal-title":"J Nanobiotechnol"},{"issue":"9","key":"3424_CR32","first-page":"835","volume":"32","author":"XF Zhao","year":"2024","unstructured":"Zhao XF, Wang Q, Sun J, Zhang AM, Chang XY, Li WG, et al. [A mechanistic study of radiotherapy on intratumoral NK cell infiltration augmentation by regulating the EZH2\/CXCL10 pathway in hepatocellular carcinoma cells]. Zhonghua Gan Zang Bing Za Zhi. 2024;32(9):835\u201344.","journal-title":"Zhonghua Gan Zang Bing Za Zhi"},{"issue":"8","key":"3424_CR33","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1158\/2326-6066.CIR-22-0017","volume":"10","author":"EH Knelson","year":"2022","unstructured":"Knelson EH, Ivanova EV, Tarannum M, Campisi M, Lizotte PH, Booker MA, et al. Activation of Tumor-Cell STING primes NK-Cell therapy. Cancer Immunol Res. 2022;10(8):947\u201361.","journal-title":"Cancer Immunol Res"},{"key":"3424_CR34","doi-asserted-by":"crossref","unstructured":"Zhang Z, Zhang C. Regulation of cGAS-STING signalling and its diversity of cellular outcomes. Nat Rev Immunol. 2025.","DOI":"10.1038\/s41577-024-01112-7"},{"issue":"14","key":"3424_CR35","doi-asserted-by":"publisher","first-page":"17543","DOI":"10.1021\/acsami.2c23107","volume":"15","author":"Y Li","year":"2023","unstructured":"Li Y, Zhu J, Zhang X, Li Y, Zhang S, Yang L, et al. Drug-Delivery nanoplatform with synergistic regulation of Angiogenesis-Osteogenesis coupling for promoting vascularized bone regeneration. ACS Appl Mater Interfaces. 2023;15(14):17543\u201361.","journal-title":"ACS Appl Mater Interfaces"},{"issue":"62","key":"3424_CR36","doi-asserted-by":"publisher","first-page":"37600","DOI":"10.1039\/D0RA07950B","volume":"10","author":"Q Wang","year":"2020","unstructured":"Wang Q, Sun Y, Li S, Zhang P, Yao Q. Synthesis and modification of ZIF-8 and its application in drug delivery and tumor therapy. RSC Adv. 2020;10(62):37600\u201320.","journal-title":"RSC Adv"},{"key":"3424_CR37","doi-asserted-by":"crossref","unstructured":"Sang D, Lin K, Yang Y, Ran G, Li B, Chen C et al. Prolonged sleep deprivation induces a cytokine-storm-like syndrome in mammals. Cell. 2023;186(25).","DOI":"10.1016\/j.cell.2023.10.025"},{"issue":"49","key":"3424_CR38","doi-asserted-by":"publisher","first-page":"e1803217","DOI":"10.1002\/adma.201803217","volume":"30","author":"Z Zhang","year":"2018","unstructured":"Zhang Z, Kuang G, Zong S, Liu S, Xiao H, Chen X, et al. Sandwich-Like fibers\/sponge composite combining chemotherapy and hemostasis for efficient postoperative prevention of tumor recurrence and metastasis. Adv Mater. 2018;30(49):e1803217.","journal-title":"Adv Mater"},{"issue":"8","key":"3424_CR39","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1158\/0008-5472.CAN-18-2395","volume":"79","author":"S Huang","year":"2019","unstructured":"Huang S, Wang Z, Zhou J, Huang J, Zhou L, Luo J, et al. EZH2 inhibitor GSK126 suppresses antitumor immunity by driving production of Myeloid-Derived suppressor cells. Cancer Res. 2019;79(8):2009\u201320.","journal-title":"Cancer Res"},{"issue":"2","key":"3424_CR40","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1158\/2326-6066.CIR-18-0317","volume":"7","author":"J Lee","year":"2019","unstructured":"Lee J, Kang TH, Yoo W, Choi H, Jo S, Kong K, et al. An antibody designed to improve adoptive NK-Cell therapy inhibits pancreatic Cancer progression in a murine model. Cancer Immunol Res. 2019;7(2):219\u201329.","journal-title":"Cancer Immunol Res"},{"issue":"1","key":"3424_CR41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13045-021-01212-0","volume":"14","author":"W Lu","year":"2021","unstructured":"Lu W, Cao F, Feng L, Song G, Chang Y, Chu Y, et al. LncRNA Snhg6 regulates the differentiation of MDSCs by regulating the ubiquitination of EZH2. J Hematol Oncol. 2021;14(1):196.","journal-title":"J Hematol Oncol"},{"key":"3424_CR42","doi-asserted-by":"publisher","first-page":"110243","DOI":"10.1016\/j.intimp.2023.110243","volume":"119","author":"J Liu","year":"2023","unstructured":"Liu J, Lin W-P, Su W, Wu Z-Z, Yang Q-C, Wang S, et al. Sunitinib attenuates reactive MDSCs enhancing anti-tumor immunity in HNSCC. Int Immunopharmacol. 2023;119:110243.","journal-title":"Int Immunopharmacol"},{"issue":"9","key":"3424_CR43","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/iub.1199","volume":"65","author":"SS Hasan","year":"2013","unstructured":"Hasan SS, Rizvi A, Naseem I. Calcitriol-induced DNA damage: toward a molecular mechanism of selective cell death. IUBMB Life. 2013;65(9):787\u201392.","journal-title":"IUBMB Life"},{"key":"3424_CR44","doi-asserted-by":"crossref","unstructured":"Prabagar MG, McQueney M, Bommireddy V, Siegel R, Schieven GL, Lu K et al. THE STING AGONIST VB-85247 INDUCES DURABLE ANTITUMOR IMMUNE RESPONSES BY INTRAVESICAL ADMINISTRATION IN A NON-MUSCLE INVASIVE BLADDER CANCER. Cancer Res. 2024.","DOI":"10.1158\/0008-5472.c.7751930"},{"issue":"12","key":"3424_CR45","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1038\/s41590-023-01659-y","volume":"24","author":"OK Dagher","year":"2023","unstructured":"Dagher OK, Posey AD. Forks in the road for CAR T and CAR NK cell cancer therapies. Nat Immunol. 2023;24(12):1994\u20132007.","journal-title":"Nat Immunol"},{"key":"3424_CR46","doi-asserted-by":"crossref","unstructured":"Hao J, Chen C, Pavelic K, Ozer F. ZIF-8 as a pH-Responsive nanoplatform for 5-Fluorouracil delivery in the chemotherapy of oral squamous cell carcinoma. Int J Mol Sci. 2024;25(17).","DOI":"10.3390\/ijms25179292"},{"key":"3424_CR47","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.actbio.2017.06.001","volume":"58","author":"J Qu","year":"2017","unstructured":"Qu J, Zhao X, Ma PX, Guo B. pH-responsive self-healing injectable hydrogel based on N-carboxyethyl Chitosan for hepatocellular carcinoma therapy. Acta Biomater. 2017;58:168\u201380.","journal-title":"Acta Biomater"},{"key":"3424_CR48","doi-asserted-by":"publisher","first-page":"4073","DOI":"10.2147\/IJN.S308057","volume":"16","author":"B Gao","year":"2021","unstructured":"Gao B, Luo J, Liu Y, Su S, Fu S, Yang X, et al. Intratumoral administration of thermosensitive hydrogel Co-Loaded with Norcantharidin nanoparticles and doxorubicin for the treatment of hepatocellular carcinoma. Int J Nanomed. 2021;16:4073\u201385.","journal-title":"Int J Nanomed"},{"issue":"12","key":"3424_CR49","doi-asserted-by":"publisher","first-page":"1898","DOI":"10.1200\/JCO.2005.04.9130","volume":"24","author":"AX Zhu","year":"2006","unstructured":"Zhu AX, Blaszkowsky LS, Ryan DP, Clark JW, Muzikansky A, Horgan K, et al. Phase II study of gemcitabine and oxaliplatin in combination with bevacizumab in patients with advanced hepatocellular carcinoma. J Clin Oncol. 2006;24(12):1898\u2013903.","journal-title":"J Clin Oncol"}],"container-title":["Journal of Nanobiotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03424-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12951-025-03424-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12951-025-03424-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T10:04:28Z","timestamp":1747389868000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnanobiotechnology.biomedcentral.com\/articles\/10.1186\/s12951-025-03424-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,16]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3424"],"URL":"https:\/\/doi.org\/10.1186\/s12951-025-03424-9","relation":{},"ISSN":["1477-3155"],"issn-type":[{"value":"1477-3155","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,16]]},"assertion":[{"value":"27 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study received the approval from the Ethics Review Board of the Third Affiliated Hospital, Sun Yat-sen University (Approval no. II2024-166-01), the Animal Care and Use Committee of Jennio Biotech Co.,Ltd (IACUC-2023-A039), and the Animal Care and Use Committee of Huateng BioScience (C202304-14).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the manuscript and agree for the submission.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"353"}}